Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Ranbaxy Laboratories has agreed to sell partner Nihon Chemiphar its 50% stake in their Japanese joint venture, Nihon Pharmaceutical Industry. Chemiphar is a Japan-based developer and manufacturer of generic drugs. The companies did not explain whether the dissolution is linked to the 2008 acquisition of Ranbaxy by Daiichi Sankyo, one of Chemiphar’s competitors in Japan. To ensure a smooth transition, Ranbaxy will supply drugs made in India to Nihon for a limited time.
This article has been sent to the following recipient: